Brief: Natco Pharma Says FDA Conducted Inspection At Natco Pharma In Kothur
18/09/2025 10:05
Sept 18 (Reuters) - Natco Pharma Ltd NATP.NS: NATCO PHARMA LTD - FDA CONDUCTED INSPECTION AT NATCO PHARMA IN KOTHUR, HYDERABAD NATCO PHARMA LTD - RECEIVES EIR CLASSIFYING FACILITY AS 'VAI' Source text: ID:nBSE8nbfJZ Further company coverage: NATP.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees